Eric Green, president, CEO and board of directors chairman of Exton-based West Pharmaceutical Services, an injectable solutions and services provider, recently informed the board of directors he plans to retire.
“After serving 11 years as the company’s sixth CEO over the past century, it is time for someone else to take over the leadership of West,” Green said. “I have great confidence in the strong leadership team we have in place to carry on with the current momentum to take this extraordinary company forward. I am especially thankful to the board of directors for giving me this stewardship to lead West over more than a decade and for their support of my decision. My decision provides the opportunity to serve in the future in other capacities, including corporate boards and advisory roles.”
Green became president and CEO in April 2015 and board chairman in May 2022. He will retire after his successor is hired.
The board of directors has hired an executive recruiting firm to help search for a successor and expects the successor will begin working during in the second half of the year.
West Pharmaceutical Services employs 10,000 people at 50 sites worldwide. It generated $3.07 billion in net sales during fiscal year 2025.